Press releases

Solid execution results in mid-single digit revenue growth, driven by broad-based strength across multiple businesses and geographies; Major innovative product approvals; Raises fiscal year...

TCT 2023: Medtronic adds to the body of evidence for Evolut TAVR with late-breaking clinical trial data from the Evolut Low Risk Trial DUBLIN and SAN FRANCISCO, Oct. 24, 2023 /PRNewswire/ --...

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Medtronic plc...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today confirmed its participation in the following upcoming investor conferences: 2023 Wells Fargo Healthcare Conference...

Broad strength across businesses and geographies results in mid-single digit revenue growth, driven by execution, innovation, and improved underlying fundamentals DUBLIN, Aug. 22, 2023...

The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 17, 2023, approved an increase in the company's cash dividend for the second quarter of fiscal year 2024 versus the prior...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual Goldman Sachs global healthcare conference on Monday, June 12, 2023....

Mid-single digit fourth quarter revenue growth exceeded expectations on broad-based strength across the company DUBLIN, May 25, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced...

AccuRhythm AI algorithms now cleared by FDA for the Reveal LINQ ICM; enhancements made to the AF algorithm for the LINQ II ICM DUBLIN, May 16, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today...

Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), has priced an offering (the "Offering") of...

ACC.23/WCC late-breaking data: PULSED AF, one of the most rigorously executed PFA clinical studies to date, exceeds safety and efficacy performance goals in the treatment of paroxysmal and...

The board of directors of Medtronic plc (NYSE:MDT) on Thursday, March 2, 2023, approved the fiscal year 2023 fourth quarter cash dividend of $0.68 per ordinary share, representing an 8% increase...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual Cowen healthcare conference on Monday, March 6, 2023. Karen Parkhill,...

Delivers top and bottom line ahead of expectations, with strength in Cardiovascular and Neuroscience portfolios DUBLIN, Feb. 21, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced...

Medtronic named to the 2023 Bloomberg Gender-Equality Index (GEI) the same week the company publishes its Global Inclusion, Diversity & Equity 2022 Annual Report DUBLIN, Feb. 1, 2023 /PRNewswire/...

The JUST 100 is the only ranking that recognizes companies doing right by all their stakeholders as defined by the American public DUBLIN, Jan. 10, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT),...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 41st annual J.P. Morgan healthcare conference. Geoff Martha, Medtronic chairman and...

Strong environmental, social, and governance (ESG) management and performance result in continued inclusion on the Dow Jones Sustainability World Index DUBLIN, Dec. 14, 2022 /PRNewswire/ --...

The board of directors of Medtronic plc (NYSE:MDT) on Thursday, December 8, 2022, approved the fiscal year 2023 third quarter cash dividend of $0.68 per ordinary share, representing an 8% increase...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the Evercore ISI 5th annual HealthCONx conference on Tuesday, November 29, 2022. Geoff...

Earnings delivered despite slower market procedure volume and supply recovery; Growth driven by TAVR, Pacing, U.S. Core Spine, and International Diabetes DUBLIN, Nov. 22, 2022 /PRNewswire/ --...

Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with Medtronic Extended infusion set DUBLIN, Nov. 15, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global...

New Medtronic Neurovascular Co-Lab™ Platform drives collaboration and connections among start-ups, physicians, and institutions; aims to improve stroke treatment and access for patients...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the company will host a webcast to provide an update on its Medtronic Coronary and Renal Denervation business...

This is the second notable recognition the company has received this week, following being named to the Fortune 2022 'Change the World' list DUBLIN, Oct. 13, 2022 /PRNewswire/ -- Medtronic plc...